Nebilet Plus (Hydrochlorothiazide, Nebivolol)

Nebivolol/Hydrochlorothiazide, the active ingredient in Nebilet Plus, is a beta‑blocker / thiazide diuretic combination presented as an oral tablet for oral use. It lowers elevated blood pressure by reducing cardiac output and plasma volume, and is indicated for the treatment of hypertension in adult patients.

GNH USA supplies Nebilet Plus as a licensed, GDP‑compliant international pharmaceutical supplier, providing reliable sourcing to hospitals, pharmacies, and clinics worldwide. The company supports global procurement with quality‑assured batches, regulatory documentation, and logistics tailored to each market.

Nebilet Plus is used in the management of hypertension, acting on the cardiovascular system to control elevated blood pressure.

- Hypertension: reduces systolic and diastolic blood pressure and lowers risk of cardiovascular complications. - Essential hypertension: provides consistent blood pressure control in primary hypertension. - High blood pressure in adults: improves overall hemodynamic stability for adult patients.

Nebilet Plus may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Fatigue or mild weakness. - Increased urination. - Electrolyte disturbances such as low potassium. - Elevated blood glucose levels.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Acute kidney injury or significant rise in serum creatinine. - Allergic reactions including rash, angioedema, or anaphylaxis. - Pancreatitis. - Severe electrolyte imbalances (e.g., hyponatremia, hyperuricemia).

Before initiating Nebilet Plus, certain precautions should be observed to ensure safe use.

- Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Renal function assessment: evaluate serum creatinine and eGFR, especially in patients with pre‑existing kidney disease. - Electrolyte surveillance: monitor potassium and sodium levels during therapy. - Diabetes caution: observe blood glucose as thiazides may raise glucose levels. - Discontinuation: avoid abrupt cessation; taper under medical guidance to prevent rebound hypertension. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Nebilet Plus can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Concomitant use with other β‑blockers may cause excessive bradycardia. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) can increase nebivolol plasma levels. - Other potent diuretics may exacerbate electrolyte loss and dehydration. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) can blunt antihypertensive efficacy.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Calcium‑channel blockers: additive blood‑pressure lowering. - Lithium: thiazide component can raise lithium concentrations. - Digoxin: monitor for increased serum levels due to altered renal clearance.